| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |